The first invasive brain-computer interface medical device has been approved for market launch, and brain-computer interface concept stocks are experiencing fluctuations

On March 13th, brain-computer interface concept stocks experienced fluctuations, with Innovation Medical and Sanbo rising nearly 10%. The National Medical Products Administration approved the market launch of the implanted brain-computer interface medical device by Bolei Kang Medical Technology, marking the entry of the world's first invasive brain-computer interface into clinical application. This product is suitable for patients with cervical spinal cord injuries and can assist in achieving hand grasping functions. The National Medical Products Administration will continue to support innovation in high-end medical devices and promote the application of new technologies in the healthcare field